Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP517664.RASu_tmzlOqbh1Njmut6j1CXeHt0w4jSGfkd6Fzhh6l0E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP517664.RASu_tmzlOqbh1Njmut6j1CXeHt0w4jSGfkd6Fzhh6l0E130_assertion type Assertion NP517664.RASu_tmzlOqbh1Njmut6j1CXeHt0w4jSGfkd6Fzhh6l0E130_head.
- NP517664.RASu_tmzlOqbh1Njmut6j1CXeHt0w4jSGfkd6Fzhh6l0E130_assertion description "[While in normal individuals all these molecules are broadly expressed on leukocytes, in patients with leukemias the following deviations were observed: (a) at least one of the examined molecules was missing in 64/68 cases (94%); in 12/68 cases (18%) both molecules LFA-1 and ICAM-1 were missing, in 37/68 (54%) either LFA-1 or ICAM-1, and in 15/68 cases (22%) adhesion molecules other than LFA-1 or ICAM-1 were missing; (b) the expression of CD11a/CE18, CD58, CD59 on leukemic cells was heterogeneous, without any clear correlation to the subclass of leukemia; (c) in the majority of cases, CD54 (45/68; 66%) and CD44 (36/68; 53%) were missing, however showing a tendency of expression on leukemic cells with more mature immunophenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP517664.RASu_tmzlOqbh1Njmut6j1CXeHt0w4jSGfkd6Fzhh6l0E130_provenance.
- NP517664.RASu_tmzlOqbh1Njmut6j1CXeHt0w4jSGfkd6Fzhh6l0E130_assertion evidence source_evidence_literature NP517664.RASu_tmzlOqbh1Njmut6j1CXeHt0w4jSGfkd6Fzhh6l0E130_provenance.
- NP517664.RASu_tmzlOqbh1Njmut6j1CXeHt0w4jSGfkd6Fzhh6l0E130_assertion SIO_000772 7935981 NP517664.RASu_tmzlOqbh1Njmut6j1CXeHt0w4jSGfkd6Fzhh6l0E130_provenance.
- NP517664.RASu_tmzlOqbh1Njmut6j1CXeHt0w4jSGfkd6Fzhh6l0E130_assertion wasDerivedFrom befree-20150227 NP517664.RASu_tmzlOqbh1Njmut6j1CXeHt0w4jSGfkd6Fzhh6l0E130_provenance.
- NP517664.RASu_tmzlOqbh1Njmut6j1CXeHt0w4jSGfkd6Fzhh6l0E130_assertion wasGeneratedBy ECO_0000203 NP517664.RASu_tmzlOqbh1Njmut6j1CXeHt0w4jSGfkd6Fzhh6l0E130_provenance.